Taft Stettinius & Hollister advised ONL Therapeutics on the transaction, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters.ONL Therapeutics, Inc. announced the…
ONL Therapeutics’ $65 Million Series D Financing Round
![](https://globallegalchronicle.com/wp-content/uploads/2024/09/onl-therapeutics-65-million-series-d-financing-round_66ed1bcd43f97.jpeg)
Taft Stettinius & Hollister advised ONL Therapeutics on the transaction, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters.ONL Therapeutics, Inc. announced the…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.